Article

Measurable Residual Disease (MRD) dynamics in Multiple Myeloma and the influence of Clonal Diversity Analyzed by Artificial Intelligence

2024-05-14

Abstract excerpt

<title>Abstract</title> <p>Minimal Residual Disease (MRD) assessment is a known surrogate marker for survival in multiple myeloma (MM). Here, we present a single institution’s experience assessing MRD by NGS of Ig genes and the long-term impact of depth of response as well as clonal diversity on the clinical outcome of a large population of MM patients; 482 MM patients at the University of California, San Francis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eccf745d-ce3b-5cfa-8482-da38eaa71050
DOI: 10.21203/rs.3.rs-4150524/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Measurable Residual Disease (MRD) dynamics in Multiple Myeloma and the influence of Clonal Diversity Analyzed by Artificial IntelligenceDOI 10.21203/rs.3.rs-4150524/v1Read

Hunting down the dominating subclone of cancer stem cells as a potential new therapeutic target in multiple myeloma: An artificial intelligence perspectiveSemantic proximity Read

Monitoring minimal residual disease in the bone marrow using next generation sequencing.Semantic proximity Read

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patientsSemantic proximity Read

Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple MyelomaSemantic proximity Read

Longitudinal multi-omic profiling uncovers immune escape and predictors of response in multiple myelomaSemantic proximity Read

Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myelomaSemantic proximity Read

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic useSemantic proximity Read

Establishing Measurable Residual Disease Trajectories for Patients on Treatment for Newly Diagnosed Multiple Myeloma as Benchmark for Deployment of T-cell Redirection TherapySemantic proximity Read

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myelomaSemantic proximity Read

Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myelomaSemantic proximity Read

Single-Cell Multiomics Reveals Regulatory Mechanisms of CAR T Cell Persistence and Dysfunction in Multiple MyelomaSemantic proximity Read

Molecular detection of minimal residual disease in multiple myelomaSemantic proximity Read